Resultados de la búsqueda 981-990 of 14762 for estradiol

  1. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to obtain serum from patients with certain rare immunobullous diseases (e.g., paraneoplastic pemphigus, laminin- ...

  2. Ensayos clínicos - Hematología

    Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

  3. Mayo Clinic

    Inicio · YouTube-Pulmonary Tests PFT Chest CT Flexible Bronchoscopy ...

  4. Oncología (médica) - Ensayos clínicos

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  6. Radioterapia de haz externo para el cáncer de próstata - Médicos y departamentos - Mayo Clinic

    Para ver todos los médicos • Todas las localizaciones · Attia, Albert N. M.D.. Florida · Davis, Brian J. M.D., Ph.D. Minnesota.

  7. Oncología (médica) - Ensayos clínicos

    The primary objective of this proposal is to develop a Thoracic Specimen Registry at Mayo Clinic. The purpose of the registry will be to support ongoing ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also, we will evaluate whether the peripheral blood immune cell function is different in B/AA prostate cancer patients with metastatic disease as compared with ...

  9. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.

  10. Oncología (médica) - Ensayos clínicos

    This trial studies how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer ...